Vall d'Hebron Institute of Oncology — Barcelona

Public research footprint of Vall d'Hebron Institute of Oncology, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · Advanced Solid Tumor · Metastatic Colorectal Cancer

Recently updated registry entries

NCT05902169 — Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU… (Recruiting)
NCT04657068 — A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (Recruiting)
NCT02486718 — Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Vall d'Hebron Institute of Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.